These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Drug therapy in pregnancy: the lessons of diethylstilbestrol, thalidomide, and bendectin. Saunders EJ; Saunders JA Health Care Women Int; 1990; 11(4):423-32. PubMed ID: 2228814 [TBL] [Abstract][Full Text] [Related]
63. Misleading meta-analyses of observational studies may generate unjustified alarms: The case of medications for nausea and vomiting in pregnancy. Biffi A; Rea F; Locatelli A; Cetin I; Filippelli A; Corrao G Pharmacol Res; 2021 Jan; 163():105229. PubMed ID: 33031909 [TBL] [Abstract][Full Text] [Related]
64. Bendectin and human congenital malformations. Shiono PH; Klebanoff MA Teratology; 1989 Aug; 40(2):151-5. PubMed ID: 2772850 [TBL] [Abstract][Full Text] [Related]
65. Drugs and stillbirth. Porter JB; Hunter-Mitchell J; Jick H; Walker AM Am J Public Health; 1986 Dec; 76(12):1428-31. PubMed ID: 3777291 [TBL] [Abstract][Full Text] [Related]
66. Bendectin and birth defects: I. A meta-analysis of the epidemiologic studies. McKeigue PM; Lamm SH; Linn S; Kutcher JS Teratology; 1994 Jul; 50(1):27-37. PubMed ID: 7974252 [TBL] [Abstract][Full Text] [Related]
67. Safety of drug therapy for nausea and vomiting of pregnancy. Huff PS J Fam Pract; 1980 Nov; 11(6):969-70. PubMed ID: 7005391 [No Abstract] [Full Text] [Related]
68. Prescription drugs in the first trimester and congenital malformations. McBride WG Aust N Z J Obstet Gynaecol; 1992 Nov; 32(4):386. PubMed ID: 1290446 [No Abstract] [Full Text] [Related]
72. Concern for truth: driving defensively when confronting a zombie epidemic. Howland RH J Psychosoc Nurs Ment Health Serv; 2013 Nov; 51(11):9-12. PubMed ID: 24124694 [TBL] [Abstract][Full Text] [Related]
73. The weight of the evidence--or--more likely than not. Melnick M J Craniofac Genet Dev Biol; 1986; 6(3):203-6. PubMed ID: 3771734 [No Abstract] [Full Text] [Related]
74. The developmental toxicity of the H1 histamine antagonists. Lione A; Scialli AR Reprod Toxicol; 1996; 10(4):247-55. PubMed ID: 8829247 [No Abstract] [Full Text] [Related]
75. Response to Dr. Brent's commentary on "Dr. Brent and scientific debate". Newman SA Reprod Toxicol; 1999; 13(4):255-60. PubMed ID: 10532797 [No Abstract] [Full Text] [Related]
76. Bendectin: review of the medical literature of a comprehensively studied human nonteratogen and the most prevalent tortogen-litigen. Scialli AR Reprod Toxicol; 1999; 13(4):239. PubMed ID: 10453907 [No Abstract] [Full Text] [Related]
77. CDC study: no evidence for teratogenicity of Bendectin. Check WA JAMA; 1979 Dec; 242(23):2518. PubMed ID: 490865 [No Abstract] [Full Text] [Related]
79. Two legal issues: expert witnesses and Bendectin case. Brushwood DB Drug Intell Clin Pharm; 1983 Nov; 17(11):848-9. PubMed ID: 6641512 [No Abstract] [Full Text] [Related]
80. FDA approval of doxylamine-pyridoxine therapy for use in pregnancy. Slaughter SR; Hearns-Stokes R; van der Vlugt T; Joffe HV N Engl J Med; 2014 Mar; 370(12):1081-3. PubMed ID: 24645939 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]